Joseph Berger (neurologist)

Last updated
Joseph Berger
Born (1951-04-19) April 19, 1951 (age 73)
Alma materPennsylvania State University, Jefferson Medical College
Known forDiscovered using Oxandrolone for the treatment of AIDS; Research on Progressive Multifocal Leukoencephalopathy (PML), and MS (Multiple Sclerosis)
SpouseSandra T. Berger
Children3

Joseph R. Berger (born April 19, 1951) is an American internist and neurologist who is known [1] [ non-primary source needed ] [2] [ non-primary source needed ] for his research interests in progressive multifocal leukoencephalopathy (PML), the neurological complications of HIV/AIDS, multiple sclerosis, and other inflammatory disorders of the brain. Particularly, he contributed research on why PML occurs more frequently in AIDS than in other immunosuppressive conditions. [3] [ non-primary source needed ]

Contents

He has also made substantial contributions to the understanding of the spectrum of neurological complications that accompany HIV infection occurring as a consequence of the direct effects of the HIV on the central and peripheral nervous systems and those that result from the accompanying immunosuppression of AIDS. Berger is the discoverer of the value of the anabolic steroid oxandrolone in the treatment of AIDS wasting and AIDS myopathy. [4] [ non-primary source needed ] He is the recipient of the 2015 Pioneer in NeuroVirology award of the International Society for NeuroVirology., [5] the 2014 Raymond D. Adams Lectureship, the 2015 Distinguished Teaching Award from the American Neurological Association [6]  ; and the 2018 Alumni Achievement Award from the Sidney Kimmel College, Thomas Jefferson University. [7]

Career and education

Berger graduated from Susquehanna Township High School in Harrisburg, PA, in 1969 and was  a summa cum laude graduate of the Pennsylvania State University (1972) – Jefferson Medical College (1974) Five-Year Accelerated Medical Program. He completed his residency in internal medicine at Georgetown University Hospital and his neurology residency at the University of Miami School of Medicine.

In 1981, Berger joined the faculty of the University of Miami School of Medicine, serving in the departments of both neurology and internal medicine. At that institution, he held the Whigham-Berger Endowed Chair for the study of the neurological complications of HIV/AIDS. [8] He is a fellow of the American Academy of Neurology, the American Neurological Association, and the American College of Physicians.

From 1995 through 2014, he was chairman of the Department of Neurology at the University of Kentucky College of Medicine, where he held the Ruth L. Works Professorship and was director of the Multiple Sclerosis Clinic and the Neuro-AIDS Program.

Berger worked in international outreach programs- as he ran a conference for the United Nations and Mother and Children's African Relief Organization in Addis Ababa, Ethiopia in 1999.

In 2014, he joined the faculty of the Perelman School of Medicine, University of Pennsylvania, as professor of neurology and was chief of the Multiple Sclerosis Division from 2014 through 2019.

Berger is the case-report editor of the Journal of NeuroVirology and serves or has served on other editorial boards. He co-founded the International Neuroscience of HIV meeting with Dr. Robert Levy, and has served in numerous administrative capacities for the American Neurological Association and the American Academy of Neurology.

Publications

Berger has published more than 275 refereed papers, more than 100 chapters, and has co-edited four textbooks,  The preponderance of his published work has focused on the progressive multifocal leukoencephalopathy, the neurological complications of HIV/AIDS and other infectious diseases, and multiple sclerosis and related inflammatory conditions; however, his contributions address a large number of other neurological conditions.

Media Appearances

Berger has appeared in lectures and on PBS news regarding the effects on the brain of COVID-19, as well other issues such as the need for more neurologists and artificial intelligence usefulness in neurology:

Neurological consequences of COVID-19 on YouTube

The inadequate supply of neurologists on YouTube

Can artificial intelligence replace neurologists on YouTube

Related Research Articles

<span class="mw-page-title-main">Neurology</span> Medical specialty dealing with disorders of the nervous system

Neurology is the branch of medicine dealing with the diagnosis and treatment of all categories of conditions and disease involving the nervous system, which comprises the brain, the spinal cord and the peripheral nerves. Neurological practice relies heavily on the field of neuroscience, the scientific study of the nervous system.

<span class="mw-page-title-main">Progressive multifocal leukoencephalopathy</span> Viral disease affecting human brains

Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal viral disease characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal). It is caused by the JC virus, which is normally present and kept under control by the immune system. The JC virus is harmless except in cases of weakened immune systems. In general, PML has a mortality rate of 30–50% in the first few months, and those who survive can be left with varying degrees of neurological disabilities.

<i>Human polyomavirus 2</i> Species of virus

Human polyomavirus 2, commonly referred to as the JC virus or John Cunningham virus, is a type of human polyomavirus. It was identified by electron microscopy in 1965 by ZuRhein and Chou, and by Silverman and Rubinstein, and later isolated in culture and named using the two initials of a patient, John Cunningham, with progressive multifocal leukoencephalopathy (PML). The virus causes PML and other diseases only in cases of immunodeficiency, as in AIDS or during treatment with immunosuppressive drugs.

<span class="mw-page-title-main">Opportunistic infection</span> Infection caused by pathogens that take advantage of an opportunity not normally available

An opportunistic infection is an infection caused by pathogens that take advantage of an opportunity not normally available. These opportunities can stem from a variety of sources, such as a weakened immune system, an altered microbiome, or breached integumentary barriers. Many of these pathogens do not necessarily cause disease in a healthy host that has a non-compromised immune system, and can, in some cases, act as commensals until the balance of the immune system is disrupted. Opportunistic infections can also be attributed to pathogens which cause mild illness in healthy individuals but lead to more serious illness when given the opportunity to take advantage of an immunocompromised host.

<span class="mw-page-title-main">Natalizumab</span> Medication used to treat multiple sclerosis and Crohns disease

Natalizumab, sold under the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. It is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. It is given by intravenous infusion. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood–brain barrier.

The CDC Classification System for HIV Infection is the medical classification system used by the United States Centers for Disease Control and Prevention (CDC) to classify HIV disease and infection. The system is used to allow the government to handle epidemic statistics and define who receives US government assistance.

HIV-associated neurocognitive disorders (HAND) are neurological disorders associated with HIV infection and AIDS. It is a syndrome of progressive deterioration of memory, cognition, behavior, and motor function in HIV-infected individuals during the late stages of the disease, when immunodeficiency is severe. HAND may include neurological disorders of various severity. HIV-associated neurocognitive disorders are associated with a metabolic encephalopathy induced by HIV infection and fueled by immune activation of macrophages and microglia. These cells are actively infected with HIV and secrete neurotoxins of both host and viral origin. The essential features of HIV-associated dementia (HAD) are disabling cognitive impairment accompanied by motor dysfunction, speech problems and behavioral change. Cognitive impairment is characterised by mental slowness, trouble with memory and poor concentration. Motor symptoms include a loss of fine motor control leading to clumsiness, poor balance and tremors. Behavioral changes may include apathy, lethargy and diminished emotional responses and spontaneity. Histopathologically, it is identified by the infiltration of monocytes and macrophages into the central nervous system (CNS), gliosis, pallor of myelin sheaths, abnormalities of dendritic processes and neuronal loss.

The central nervous system (CNS) controls most of the functions of the body and mind. It comprises the brain, spinal cord and the nerve fibers that branch off to all parts of the body. The CNS viral diseases are caused by viruses that attack the CNS. Existing and emerging viral CNS infections are major sources of human morbidity and mortality.

Diane Edmund Griffin is the university distinguished professor and a professor in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, where she was the department chair from 1994-2015. She is also the current vice-president of the National Academy of Sciences. She holds joint appointments in the departments of Neurology and Medicine. In 2004, Griffin was elected to the United States National Academy of Sciences (NAS) in the discipline of microbial biology.

Richard T. Johnson was a physician and scientist at the Johns Hopkins University School of Medicine. Johnson was a faculty member in the Department of Neurology since its inception in 1969 and was the former head of the department. His research into the effects of viruses on the central nervous system has been published in over 300 scientific articles, and Johnson was both a journal and book editor and the author of an influential textbook, Viral Infections of the Nervous System.

Neurovirology is an interdisciplinary field which represents a melding of clinical neuroscience, virology, immunology, and molecular biology. The main focus of the field is to study viruses capable of infecting the nervous system. In addition to this, the field studies the use of viruses to trace neuroanatomical pathways, for gene therapy, and to eliminate detrimental populations of neural cells.

Eugene O. "Gene" Major is a senior investigator at the National Institute of Neurological Disorders and Stroke (NINDS), a part of the United States National Institutes of Health (NIH). Major conducts research into the neurological diseases including progressive multifocal leukoencephalopathy (PML), caused by JC virus and often found in immunosuppressed patients such as those with HIV/AIDS. Major has published over 140 scientific articles and reviews in the peer-reviewed literature and has contributed to Fields Virology, a standard virology textbook.

Avindra "Avi" Nath, is a physician-scientist who specializes in neuroimmunology. Nath is a senior investigator, and intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in the United States. At NINDS, Nath also leads the Section of Infections of the Nervous System and plans to institute a translational research center. He previously served in several research and administrative positions at the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.

Vaccinia immune globulin (VIG) is made from the pooled blood of individuals who have been inoculated with the smallpox vaccine. The antibodies these individuals developed in response to the smallpox vaccine are removed and purified. This results in VIG. It can be administered intravenously. It is used to treat individuals who have developed progressive vaccinia after smallpox vaccination.

The International Society for NeuroVirology (ISNV) was founded to promote research into disease-causing viruses that infect the human brain and nervous system. The ISNV membership includes scientists and clinicians from around the world who work in the fields of basic, translational, and clinical neurovirology.

Igor Koralnik is an American physician, neurologist and scientist. He is one of the first physicians to study the neurologic complications caused by the human immunodeficiency virus (HIV) and is a leading researcher in the investigation of the polyomavirus JC, which causes progressive multifocal leukoencephalopathy (PML), a disease of the central nervous system that occurs in immunosuppressed individuals.

<span class="mw-page-title-main">Amanda M. Brown</span> American immunologist and microbiologist

Amanda Brown is an American immunologist and microbiologist as well as an associate professor of neurology and neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland. Brown is notable for cloning one of the first recombinant HIV viruses and developing a novel method to visualize HIV infected cells using GFP fluorescence.

Valerie E. Wojna Muñiz is a Puerto Rican neurologist and professor of neurology at University of Puerto Rico, Medical Sciences Campus.

Howard E. Gendelman is an American physician-scientist whose research intersects the disciplines of neuroimmunology, pharmacology, and infectious diseases. Gendelman was born in Philadelphia, Pennsylvania. His research is focused on harnessing immune responses for therapeutic gain in HIV/AIDS and Neurodegenerative disease. He is the Margaret R. Larson Professor of infectious diseases and internal medicine at the University of Nebraska Medical Center (UNMC) in Omaha.

References

  1. Berger, JR; Kaszovitz, B; Post, MJ; Dickinson, G (1987). "Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases". Annals of Internal Medicine. 107 (1): 78–87. doi:10.7326/0003-4819-107-1-78. PMID   3296901.
  2. Berger, JR; Houff, S (2006). "Progressive multifocal leukoencephalopathy: Lessons from AIDS and natalizumab". Neurological Research. 28 (3): 299–305. doi:10.1179/016164106X98198. PMID   16687057. S2CID   6341466.
  3. Berger, Joseph (2003). "Progressive Multifocal Leukoencephalopathy in Acquired Immunodeficiency Syndrome: Explaining the High Incidence and Disproportionate Frequency of the Illness Relative to Other Immunosuppressive Conditions". Journal of Neurovirology. 9 (2): 38–41. doi:10.1080/13550280390195261. PMID   12709870. S2CID   17171153.
  4. Berger, JR; Pall, L; Hall, CD; Simpson, DM; Berry, PS; Dudley, R (1996). "Oxandrolone in AIDS-wasting myopathy". AIDS. 10 (14): 1657–62. doi:10.1097/00002030-199612000-00010. PMID   8970686. S2CID   9832782.
  5. ISNV Pioneer
  6. "Distinguished Neurology Teacher Award | American Neurological Association (ANA)". myana.org. Retrieved 2022-01-07.
  7. "Sidney Kimmel Medical College Alumni Awards". www.jefferson.edu. Retrieved 2022-01-07.
  8. "CAMPUS LIFE: Miami; Endowed Chair Recalls Friend Who Had AIDS". The New York Times. 1992-02-09. ISSN   0362-4331 . Retrieved 2022-01-07.